Search Results

Foghorn ® Therapeutics Inc. today announced that the Company will present new data at Hanson Wade’s 5th Annual Targeted Protein Degradation Summit.

Synaptogenix, Inc. (Nasdaq: SNPX) (“Synaptogenix” or the “Company”), an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, announced today that Dr. Daniel Alkon, the Company’s President and Chief Scientific Officer, will present at the Hanson Wade 10th Annual Neurodegenerative Drug Development Summit.

Avalyn Pharma Inc. announced that CFO Marc Schneebaum will present at the H.C. Wainwright 2nd Annual Private Company Showcase, which is taking place June 20-22, 2023 on Kiawah Island, SC.

deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification for sepsis and other acute infections, announces the appointments of Dr Kimberle Chapin as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer.

3M announced the appointment of Bryan C. Hanson as Chief Executive Officer of the independent health care company when it is spun off from 3M.

MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted, novel therapeutics to improve the lives of people with brain disorders, announced the appointment of Kris Hanson as the company’s General Counsel.

Women are already underrepresented in clinical trials; the new abortion and IVF laws could make it worse.

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted therapies for life-threatening pulmonary diseases, announced that CEO Lyn Baranowski will lead a workshop during the annual Hanson & Wade IPF Summit on September 19, 2023.

UroDev Medical, a medical device company working to improve the quality of life for people who suffer from neurogenic bladder and chronic urinary retention, recently announced the appointment of Jayme Hanson to its board of directors.